Jauze, Louisa
26  results:
Search for persons X
?
6

A novel therapeutic strategy for skeletal disorders: Proof ..:

Zhukouskaya, Volha ; Jauze, Louisa ; Charles, Séverine...
info:eu-repo/semantics/altIdentifier/doi/10.1126/sciadv.abj5018.  , 2021
 
?
7

A novel therapeutic strategy for skeletal disorders: Proof ..:

Zhukouskaya, Volha ; Jauze, Louisa ; Charles, Séverine...
info:eu-repo/semantics/altIdentifier/doi/10.1126/sciadv.abj5018.  , 2021
 
?
8

A novel therapeutic strategy for skeletal disorders: Proof ..:

Zhukouskaya, Volha ; Jauze, Louisa ; Charles, Séverine...
info:eu-repo/semantics/altIdentifier/doi/10.1126/sciadv.abj5018.  , 2021
 
?
9

A novel therapeutic strategy for skeletal disorders: Proof ..:

Zhukouskaya, Volha ; Jauze, Louisa ; Charles, Séverine...
info:eu-repo/semantics/altIdentifier/doi/10.1126/sciadv.abj5018.  , 2021
 
?
10

A novel therapeutic strategy for skeletal disorders: Proof ..:

Zhukouskaya, Volha ; Jauze, Louisa ; Charles, Séverine...
info:eu-repo/semantics/altIdentifier/doi/10.1126/sciadv.abj5018.  , 2021
 
?
11

A novel therapeutic strategy for skeletal disorders: Proof ..:

Zhukouskaya, Volha ; Jauze, Louisa ; Charles, Séverine...
info:eu-repo/semantics/altIdentifier/doi/10.1126/sciadv.abj5018.  , 2021
 
?
12

A novel therapeutic strategy for skeletal disorders: Proof ..:

Zhukouskaya, Volha ; Jauze, Louisa ; Charles, Séverine...
info:eu-repo/semantics/altIdentifier/doi/10.1126/sciadv.abj5018.  , 2021
 
?
13

A novel therapeutic strategy for skeletal disorders: Proof ..:

Zhukouskaya, Volha ; Jauze, Louisa ; Charles, Séverine...
info:eu-repo/semantics/altIdentifier/doi/10.1126/sciadv.abj5018.  , 2021
 
?
14

Deep morphological analysis of muscle biopsies from type II..:

Laforêt, Pascal ; Inoue, Michio ; Goillot, Evelyne...
info:eu-repo/semantics/altIdentifier/doi/10.1186/s40478-019-0815-2.  , 2019
 
?
15

Deep morphological analysis of muscle biopsies from type II..:

Laforêt, Pascal ; Inoue, Michio ; Goillot, Evelyne...
info:eu-repo/semantics/altIdentifier/doi/10.1186/s40478-019-0815-2.  , 2019
 
1-15